Cargando…

Association of β-blocker use with survival and pulmonary function in patients with chronic obstructive pulmonary and cardiovascular disease: a systematic review and meta-analysis

AIMS: The aim of this study was to clarify the effect of β-blockers (BBs) on respiratory function and survival in patients with chronic obstructive pulmonary disease with cardiovascular disease (CVD), as well as the difference between the effects of cardioselective and noncardioselective BBs. METHOD...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Yan-Li, Xiang, Zi-Jian, Yang, Jing-Hua, Wang, Wen-Jie, Xu, Zhi-Chun, Xiang, Ruo-Lan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7752251/ https://www.ncbi.nlm.nih.gov/pubmed/33211823 http://dx.doi.org/10.1093/eurheartj/ehaa793

Ejemplares similares

Increase use of β-blockers in patients with chronic obstructive pulmonary and cardiovascular disease
por: Yang, Yan-Li, et al.
Publicado: (2021)

Underuse of β-blockers in heart failure and chronic obstructive pulmonary disease
por: Lipworth, Brian, et al.
Publicado: (2016)

Beta-blockers use in patients with chronic obstructive pulmonary disease and concomitant cardiovascular conditions
por: Albouaini, Khaled, et al.
Publicado: (2007)

Chronic obstructive pulmonary disease and β‐blocker treatment in Asian patients with heart failure
por: Kubota, Yoshiaki, et al.
Publicado: (2017)

Different Non-selective β-Blocker Therapy and Risk of Chronic Obstructive Pulmonary Disease
por: Wang, Cheng-Yi, et al.
Publicado: (2019)

Certainties fading away: β-blockers do not worsen chronic obstructive pulmonary disease
por: Verdecchia, Paolo, et al.
Publicado: (2021)

Adverse Effects Associated With Currently Commonly Used Antifungal Agents: A Network Meta-Analysis and Systematic Review
por: Yang, Yan-Li, et al.
Publicado: (2021)

A risk prediction model for acute kidney injury in patients with pulmonary tuberculosis during anti-tuberculosis treatment
por: Du, Zhi Xiang, et al.
Publicado: (2022)

Effect of β blockers in treatment of chronic obstructive pulmonary disease: a retrospective cohort study
por: Short, Philip M, et al.
Publicado: (2011)

Effect of Perioperative β-Blockers on Pulmonary Complications among Patients with Chronic Obstructive Pulmonary Disease Undergoing Lung Resection Surgery
por: Kamath, A., et al.
Publicado: (2015)

Pulmonary Venous Obstruction in Cancer Patients
por: Liaw, Chuang-Chi, et al.
Publicado: (2015)

Beta-blocker Use in Moderate and Severe Chronic Obstructive Pulmonary Disease
por: Zvizdic, Faris, et al.
Publicado: (2019)

The incidence and relative risk of adverse events in patients treated with bisphosphonate therapy for breast cancer: a systematic review and meta-analysis
por: Yang, Yan-Li, et al.
Publicado: (2019)

Multimodality cardiovascular imaging in pulmonary embolism
por: Kim, Hyung Yoon, et al.
Publicado: (2021)

Intrauterine Cardiac Intervention for Fetal Pulmonary Valve Obstruction Lesion
por: Yu, Jin-Jin, et al.
Publicado: (2018)

β-blockers after acute myocardial infarction in patients with chronic obstructive pulmonary disease: A nationwide population-based observational study
por: Su, Tse-Hsuan, et al.
Publicado: (2019)

Analysis of high-resolution computed tomography phenotypes and pulmonary function in chronic obstructive pulmonary disease
por: He, Shi-Zhen, et al.
Publicado: (2020)

β-Blockers for the prevention of acute exacerbations of chronic obstructive pulmonary disease (βLOCK COPD): a randomised controlled study protocol
por: Bhatt, Surya P, et al.
Publicado: (2016)

Impact of β-blocker selectivity on long-term outcomes in congestive heart failure patients with chronic obstructive pulmonary disease
por: Kubota, Yoshiaki, et al.
Publicado: (2015)

Effect of beta-blockers on exacerbation rate and lung function in chronic obstructive pulmonary disease (COPD)
por: Duffy, Sean, et al.
Publicado: (2017)

β-Blocker Therapy and Risk of Chronic Obstructive Pulmonary Disease – A Danish Nationwide Study of 1·3 Million Individuals
por: Nielsen, Anne Orholm, et al.
Publicado: (2019)

Efficiency and Safety of Pulmonary Rehabilitation in Acute Exacerbation of Chronic Obstructive Pulmonary Disease
por: He, Mei, et al.
Publicado: (2015)

Effectiveness and Economic Evaluation of Hospital-Outreach Pulmonary Rehabilitation for Patients with Chronic Obstructive Pulmonary Disease
por: Zhang, Aidi, et al.
Publicado: (2020)

Evidence of potential bias in a comparison of β blockers and calcium channel blockers in patients with chronic obstructive pulmonary disease and acute coronary syndrome: results of a multinational study
por: Dong, Yaa-Hui, et al.
Publicado: (2017)

Cardiovascular Comorbidity in Patients with Chronic Obstructive Pulmonary Disease: Echocardiography Changes and Their Relation to the Level of Airflow Limitation
por: Buklioska-Ilievska, Daniela, et al.
Publicado: (2019)

Blood eosinophil count-guided corticosteroid therapy and as a prognostic biomarker of exacerbations of chronic obstructive pulmonary disease: a systematic review and meta-analysis
por: Liu, Tao, et al.
Publicado: (2021)

Narratives of breathlessness in chronic obstructive pulmonary disease
por: Kvangarsnes, Marit, et al.
Publicado: (2013)

Physiotherapy in Patients with Chronic Obstructive Pulmonary Disease
por: Dimitrova, Antoaneta, et al.
Publicado: (2017)

Long-acting antimuscarinic therapy in patients with chronic obstructive pulmonary disease receiving beta-blockers
por: Chapman, Kenneth R., et al.
Publicado: (2021)

An evaluation of activity tolerance, patient-reported outcomes and satisfaction with the effectiveness of pulmonary daoyin on patients with chronic obstructive pulmonary disease
por: Zhang, Hai-long, et al.
Publicado: (2017)

Value of the neutrophil-to-lymphocyte ratio in chronic obstructive pulmonary disease complicated with pulmonary hypertension
por: Jiang, Tingting, et al.
Publicado: (2023)

Association between serum adiponectin concentrations and chronic obstructive pulmonary disease: a meta-analysis
por: Lin, Yi-Hua, et al.
Publicado: (2020)

Imbalance between subsets of CD8(+) peripheral blood T cells in patients with chronic obstructive pulmonary disease
por: Chen, Long, et al.
Publicado: (2016)

Pulmonary embolism with chronic obstructive pulmonary disease
por: Yang, Ruohan, et al.
Publicado: (2021)

Daily activities are sufficient to induce dynamic pulmonary hyperinflation and dyspnea in chronic obstructive pulmonary disease patients
por: Castro, Antonio A.M., et al.
Publicado: (2012)

Preoperative pulmonary rehabilitation in patients with non-small cell lung cancer and chronic obstructive pulmonary disease
por: Mujovic, Natasa, et al.
Publicado: (2014)

Association of Serum Galectin-3 with the Acute Exacerbation of Chronic Obstructive Pulmonary Disease
por: Feng, Wei, et al.
Publicado: (2017)

Association between the TGF-β1 polymorphisms and chronic obstructive pulmonary disease: a meta-analysis
por: Liao, Ning, et al.
Publicado: (2017)

Predictors of exacerbation frequency in chronic obstructive pulmonary disease
por: Yang, Hui, et al.
Publicado: (2014)

Pulmonary Embolism after Relief of Urinary Obstruction
por: Sakamoto, Sumie, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2kil05ht2plh1qos2qfmm09vem